| 1. |
VALHALLA, N.Y. (October 28, 2022) – Westchester Medical Center and the New York State Nurses Association (NYSNA) announced a new ratified five-year collective bargaining agreement that will benefit more than 1,500 nurses at Westchester Medical Center, Maria Fareri Children's Hospital, and the Behavioral Health Center. The agreement, which is the result of a strong working relationship and commitment to bargaining in good faith, increases nurse wages, preserves existing healthcare and pension benefits, a...
|
| 2. |
|
| 3. |
Patients who have an increased risk of stroke due to an irregular heartbeat called atrial fibrillation and who cannot use blood thinners can now take advantage of a lifesaving alternative offered at Westchester Medical Center, the flagship of the Westchester Medical Center Health Network (WMCHealth). As a regional leader in cardiac care, Westchester Medical Center has begun offering a new technology called the WATCHMAN, which offers a catheter-based alternative to blood thinners for preventing st...
|
| 4. |
- Site Map Content
- 10/18/2024
|
| 5. |
Westchester Medical Center heart specialists are now using a new heart disease therapy – newly approved by the U.S. Food and Drug Administration (FDA) - they believe is an advancement in the treatment of a genetic condition - hypertrophic cardiomyopathy (HCM) - that can lead to severe heart failure. Westchester Medical Center has the only HCM program in the Hudson Valley with FDA approval for the medication's use, thus offering patients with qualifying criteria* a promising alternative to traditional tr...
|
| 6. |
You can find all the information on the CIR website: https://www.cirseiu.org/westchester-medical-center/ Salary 10/01/2019 - 09/30/2020 PGY Year Annual Salary 1 $64,260 2 $67,626 3 $70,747 4 $72,828 There is an automatic raise effective: 10/01/2020 PGY Year Annual Salary 1 $65,545 2 $68,979 3 $72,162 4 $74,285 Vacation Vacation for all house staff officers shall be 4 weeks from July 1 through June 30 each year. Vacation is typically scheduled one week at a time. Before the annual rot...
- Site Map Content
- 5/31/2023
|
| 7. |
CONTACT: Andy LaGuardia (914) 493-6532 andrew.laguardia@wmchealth.org New, Cutting-Edge eHealth Center with Telehealth Technology to Provide Care Teams with Additional Support Valhalla, New York – In a major step to enhance patient care throughout the Hudson Valley, the Westchester Medical Center Health Network (WMCHealth) unveiled its new, technology-driven eHealth program, an initiative that is expected to improved patient outcomes throughout the Hudson Valley. At the core of WMCHealth’s e...
|
| 8. |
Hematology: Clinical Studies Open For Enrollment Allogeneic Stem Cell Transplant to Induce Mixed Donor Chimerism in Patients with Sickle Cell Disease & Thalassemia NYMC 556 A prospective Natural History Study of Diagnosis, Treatment and Outcomes of Children with SCID Disorders The use of dose dense rituximab for high risk patients with newly diagnosed acute immune thrombocytopenic purpura A Pilot Study to Determine the Safety of Defibrotide in Children with High Risk Kawasaki Disease (NYMC-204) NYMC...
- Site Map Content
- 1/30/2025
|
| 9. |
Cellular Therapies: Clinical Studies Open For Enrollment Allogeneic Stem Cell Transplant to Induce Mixed Donor Chimerism in Patients with Sickle Cell Disease & Thalassemia NYMC 556 Cancer and Blood & Marrow Transplantation Wellness & Survivorship Research Registry Safety and Efficacy of Prophylactic Defibrotide Administration in Children, Adolescents and Young Adults with Sickle Cell Disease Following Myeloablative Conditioning (MAC) & Haploidentical Stem Cell Transplantation Utilizing C...
- Site Map Content
- 5/31/2023
|
| 10. |
Oncology: Clinical Studies Open For Enrollment Lymphoma Leukemia Solid Tumors Brain Tumors Urology Radiation Medicine Transplants Myeloma Sarcoma Lymphoma Immunochemotherapy with Obinutuzumab, Ifosfamide, Carboplatin and Etoposide (O-ICE) in CAYA with recurrent refractory CD20+ Mature B-NHL Pilot Study Using Induction Chemo-immunotherapy followed by Consolidation with Reduced Toxicity Conditioning and Allogenic Stem Cell Transplant in Advanced Stage Mature Non-anaplastic T-Cell or N...
- Site Map Content
- 1/31/2025
|
| 11. |
Welcome! Please View Our Campus Tour
- Site Map Content
- 1/9/2025
|